Your browser doesn't support javascript.
loading
Synchronous Pulmonary Adenocarcinomas.
Pagan, Carlos A; Shu, Catherine A; Crapanzano, John P; Lagos, Galina G; Stoopler, Mark B; Rizvi, Naiyer A; Heymann, Jonas J; Sonett, Joshua R; Fernandes, Helen; Saqi, Anjali.
Afiliação
  • Pagan CA; Department of Pathology and Cell Biology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
  • Shu CA; Department of Medical Oncology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
  • Crapanzano JP; Department of Pathology and Cell Biology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
  • Lagos GG; Department of Medical Oncology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
  • Stoopler MB; Department of Medical Oncology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
  • Rizvi NA; Department of Medical Oncology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
  • Heymann JJ; Department of Pathology and Cell Biology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
  • Sonett JR; Department of Thoracic Surgery, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
  • Fernandes H; Department of Pathology and Cell Biology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
  • Saqi A; Department of Pathology and Cell Biology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
Am J Clin Pathol ; 154(1): 57-69, 2020 06 08.
Article em En | MEDLINE | ID: mdl-32146481
ABSTRACT

OBJECTIVES:

To determine concordance/discordance between morphology and molecular testing (MT) among synchronous pulmonary carcinomas using targeted next generation sequencing (NGS), with and without comprehensive molecular review (CMR), vs analyses of multiple singe genes (non-NGS).

METHODS:

Results of morphologic and MT assessment were classified as concordant, discordant, or indeterminate. For discordant cases, comprehensive histologic assessment (CHA) was performed.

RESULTS:

Forty-seven cases with 108 synchronous tumors were identified and underwent MT (NGS, n = 23 and non-NGS, n = 24). Histology and MT were concordant, discordant, and indeterminate in 53% (25/47), 21% (10/47), and 26% (12/47) of cases, respectively. CHA of the 10 discordant cases revised results of three cases.

CONCLUSIONS:

There is discordance between histology and MT in a subset of cases and MT provides an objective surrogate for staging synchronous tumors. A limited gene panel is sufficient for objectively assessing a relationship if the driver mutations are distinct. Relatedness of mutations require CMR with a larger NGS panel (eg, 50 genes).
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares / Metástase Neoplásica / Neoplasias Primárias Múltiplas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares / Metástase Neoplásica / Neoplasias Primárias Múltiplas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article